JP2023518829A - 糖尿病の治療方法 - Google Patents

糖尿病の治療方法 Download PDF

Info

Publication number
JP2023518829A
JP2023518829A JP2022557164A JP2022557164A JP2023518829A JP 2023518829 A JP2023518829 A JP 2023518829A JP 2022557164 A JP2022557164 A JP 2022557164A JP 2022557164 A JP2022557164 A JP 2022557164A JP 2023518829 A JP2023518829 A JP 2023518829A
Authority
JP
Japan
Prior art keywords
subject
diabetes
day
study
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022557164A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023518829A5 (https=
Inventor
エー．ディナレロ チャールズ
Original Assignee
オラテック セラピューティクス リミティド ライアビリティ カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オラテック セラピューティクス リミティド ライアビリティ カンパニー filed Critical オラテック セラピューティクス リミティド ライアビリティ カンパニー
Publication of JP2023518829A publication Critical patent/JP2023518829A/ja
Publication of JP2023518829A5 publication Critical patent/JP2023518829A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
JP2022557164A 2020-03-25 2021-03-22 糖尿病の治療方法 Pending JP2023518829A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062994486P 2020-03-25 2020-03-25
US62/994,486 2020-03-25
PCT/US2021/023497 WO2021194975A1 (en) 2020-03-25 2021-03-22 Method for treating diabetes

Publications (2)

Publication Number Publication Date
JP2023518829A true JP2023518829A (ja) 2023-05-08
JP2023518829A5 JP2023518829A5 (https=) 2024-03-29

Family

ID=77890597

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022557164A Pending JP2023518829A (ja) 2020-03-25 2021-03-22 糖尿病の治療方法

Country Status (7)

Country Link
US (1) US12569463B2 (https=)
EP (1) EP4132505A4 (https=)
JP (1) JP2023518829A (https=)
CN (1) CN115279363A (https=)
AU (1) AU2021244313A1 (https=)
MX (1) MX2022011651A (https=)
WO (1) WO2021194975A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115089572A (zh) * 2022-07-18 2022-09-23 南通大学 一种化合物olt1177在制备治疗2型糖尿病药物制剂中的应用
CN119632971A (zh) * 2024-09-10 2025-03-18 浙江大学 一种达泮舒腈的应用及药物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020503358A (ja) * 2017-01-06 2020-01-30 オラテック セラピューティクス リミティド ライアビリティ カンパニー 心血管疾患を治療する方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018204764A1 (en) * 2017-05-05 2018-11-08 Camp4 Therapeutics Corporation Identification and targeted modulation of gene signaling networks
CN111094242B (zh) * 2017-07-24 2024-02-09 诺华股份有限公司 用于治疗与nlrp活性相关的病症的化合物和组合物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020503358A (ja) * 2017-01-06 2020-01-30 オラテック セラピューティクス リミティド ライアビリティ カンパニー 心血管疾患を治療する方法

Non-Patent Citations (14)

* Cited by examiner, † Cited by third party
Title
ANNALS OF THE RHEUMATIC DISEASES, vol. Vol. 78 Supp. Supplement1, JPN6025008324, 2019, pages 70 - 71, ISSN: 0005833936 *
BIOMOLECULES, vol. 9, no. 12, JPN6025036477, 9 December 2019 (2019-12-09), pages 850, ISSN: 0005833941 *
CELL DEATH AND DISEASE, vol. 10:128, JPN6025008315, 2019, ISSN: 0005677632 *
DIABETES, vol. 62, no. 1, JPN6025036479, 13 December 2012 (2012-12-13), pages 194 - 204, ISSN: 0005833943 *
EMBO. MOL. MED., vol. 10: e8689, JPN6025008320, 2018, ISSN: 0005833938 *
FRONT. IMMUNOL., vol. 10:2538, JPN6025008323, 2019, ISSN: 0005677635 *
FRONTIERS IN PHYSIOLOGY, vol. Vol. 9:114, JPN6025036480, 20 February 2018 (2018-02-20), ISSN: 0005833940 *
J. CARDIOVASC PHARMACOL, vol. Volume 74, Number 4, JPN6025008322, 2019, pages 297 - 305, ISSN: 0005677634 *
J. EXP. MED., vol. 214, no. 11, JPN6025008321, 2017, pages 3219 - 3238, ISSN: 0005833937 *
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, JPN6025008316, 2019, pages 285 - 296, ISSN: 0005677631 *
NATURE COMMUNICATIONS, vol. 9:2550, JPN6025008319, 2018, ISSN: 0005833939 *
PNAS, vol. 115 (7), JPN6025008317, 2018, pages 1530 - 1539, ISSN: 0005677630 *
SCIENCE, vol. 327, no. 5963, JPN6025036478, 15 January 2010 (2010-01-15), pages 296 - 300, ISSN: 0005833942 *
日本内科学会雑誌, vol. 108巻9号, JPN6025008314, 2019, pages 1902 - 1911, ISSN: 0005677633 *

Also Published As

Publication number Publication date
US12569463B2 (en) 2026-03-10
MX2022011651A (es) 2022-10-13
EP4132505A4 (en) 2024-04-24
CN115279363A (zh) 2022-11-01
AU2021244313A1 (en) 2022-11-17
EP4132505A1 (en) 2023-02-15
US20230028615A1 (en) 2023-01-26
WO2021194975A1 (en) 2021-09-30

Similar Documents

Publication Publication Date Title
Scheen Clinical pharmacokinetics of metformin
EP1933862B1 (en) Methods and compositions for oral administration of proteins
EP3538158B1 (en) Treatment for fibrosis
RU2623023C2 (ru) Ликсисенатид и метформин для лечения диабета типа 2
JP2026048629A (ja) エキセンディン（９－３９）の緩衝製剤
Anderson et al. Dapagliflozin for the treatment of type 2 diabetes
CN105903005A (zh) 用于口服给予艾塞那肽的方法和组合物
US20250000933A1 (en) Terlipressin compositions and their methods of use
US12569463B2 (en) Method for treating diabetes
CN1248170A (zh) 含人体生长激素和皮质甾醇合成抑制剂的用于治疗代谢综合症的制剂
Heo et al. Pioglitazone as add-on therapy in patients with type 2 diabetes mellitus inadequately controlled with dapagliflozin and metformin: double-blind, randomized, placebo-controlled trial
EP4294419A2 (en) Tirzepatide therapeutic methods
RU2371195C2 (ru) Способ лечения вирусных инфекций
Lin et al. Effects of antacids and food on absorption of famotidine.
US20200170990A1 (en) Method for treating schnitzler's syndrome
EP2063909B1 (en) Formulations for therapeutic administration of thyroid stimulating hormone (TSH)
US20210100872A1 (en) Pharmacological Formulation Comprising Cyclo (HIS-PRO) As Effective Ingredient For Preventing Or Treating Diabetes Mellitus
US12472236B2 (en) Compositions and methods for treating diabetes
Zaqia et al. Profile of the combination of two oral anti-diabetes drugs in patients diabetes melitus at Citra Husada hospital Jember
WO2019046952A1 (en) SUBCUTANEOUS PHARMACEUTICAL PREPARATION COMPRISING INSULIN (S) AND ANTI-INFLAMMATORY AGENT FOR REDUCING TISSUE INFLAMMATORY RESPONSE IN DIABETIC PATIENTS
CN110062634A (zh) 非酒精性脂肪肝病患者中纤维化的抑制
JP2023518645A (ja) Ｇｌｐ－１の投薬レジメン
HK40008997A (en) Inhibition of fibrosis in non-alcoholic fatty liver disease patients
EA044268B1 (ru) Способ лечения неалкогольной жировой болезни печени

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240318

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240318

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250304

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250902

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20251201

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260302

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20260407